ARTICLE | Clinical News
Qutenza capsaicin regulatory update
November 23, 2009 8:00 AM UTC
FDA approved an NDA from NeurogesX for Qutenza capsaicin patch to manage neuropathic pain due to postherpetic neuralgia (PHN). The company expects to launch the dermal patch containing capsaicin, a va...